University of Wisconsin
School of Medicine and Public Health

Fellow Publications

The following list includes research publications authored by University of Wisconsin Hematology/Oncology Fellows from 2013-2016.


  • Rena Shah, Anita Turk, Bilal Rahim, Waddah Arafat, Moniba Nazeef and Ryan J. Mattison. Inferior Vena Cava Filter ‐ Appropriate use and Retrieval. Blood 2016 128:5912;
  • Jin N, Lubner SJ, Mulkerin DL, Rajguru S, Carmichael L, Chen H, Holen KD, LoConte NK. A Phase II Trial of a Histone Deacetylase Inhibitor Panobinostat in Patients With Low-Grade Neuroendocrine Tumors. Oncologist. 2016 Jun 3. pii: theoncologist.2016-0060.
  • Heninger, E., T. E. Krueger, S. M. Thiede, J. M. Sperger, B. L. Byers, M. R. Kircher, D. Kosoff, B. Yang, D. F. Jarrard, D. G. McNeel, and J. M. Lang. "Inducible Expression of Cancer-Testis Antigens in Human Prostate Cancer." Oncotarget  (Oct 17 2016).
  • Therapeutic Implications of Tumor-Associated Macrophages in Prostate Cancer. David Kosoff. Wisconsin Association of Hematology and Oncology Annual Meeting - Milwaukee, WI. September 23, 2016
  • Turk A, Chan N, Leal T, O'Regan R, Tevaarwerk A, Rice L, Campbell T, Barroilhet L, Mehnert J, Eickhoff J, Kolesar J, Liu G, Wisinski K. Abstract P4-22-21: NCI 9782 A phase 1 study of talazoparib in combination with carboplatin and paclitaxel in patients with advanced solid tumors. San Antonio Breast Cancer Symposium 2016 Poster 
  • J Kratz,  A Turk, C Sievers, L Clipson, K Matkowskyj, D Deming. "Molecular Profiles Guide Colorectal Cancer Treatment." Fed Pract. 2016 May;33(suppl 4):50S-53S
  • A Turk, D Deming. "BRAF Mutation in Colorectal Cancer." Personalized Medicine in Oncology. 2016 Feb 5(1).


  • Gahvari ZJ, LoConte NK, Lubner SJ, et al. Nab-paclitaxel and gemcitabine for the treatment of pancreatic adenocarcinoma at an academic center. J Clin Oncol. 33, 2015 (suppl; abstr e15261)
  • Benjamin P. Casavant, David Kosoff, Joshua M. Lang. "Directing Circulating Tumor Cell Technologies into Clinical Practice: Clinical Needs, Technology Development, and Regulatory Requirements". Circulating Tumor Cells: Isolation and Analysis, 1st Edition. Wiley Publishing. Z. Hugh Fan, Ed. 2015
  • Rocque GB, Mullvain JA, Eickhoff J, Cleary JF, Campbell TC. Integrating Palliative Care into the Oncology Clinic: A joint management approach.  Palliative Medicine.  2015; epub ahead of print.
  • Lubner SJ, Mullvain JA, Hall LT, Pishvaian M, Mortimer JE, Oliver K, Heideman J, Weichert J, Liu G.  A Phase I, Multi-Center, Open-Label, Dose-Escalation Study of 131I-CLR1404 in Subjects with Relapsed or Refractory Advanced Solid Malignancies.  Cancer Investigation.  2015; epub ahead of print.
  • Mullvain JA, Kozak KR, Moody JS, Campbell TC.  Statin Use in Cancer Patients with Brain Metastases: A Missed Communication Opportunity at the End of Life. Journal of Supportive Care in Cancer.  2015; 23(9): 2643-2648.
  • Mullvain JA, Leal T, Eickhoff J, Kolesar JM, Liu G, DiPaola RS, Wisinski KB.
  • San Antonio Breast Cancer Symposium, Poster Session, Carbone Cancer Center, University of Wisconsin.      A phase I study of BMN 673 in combination with carboplatin and paclitaxel in patients with advanced solid tumors (NCI 9782).
  • Nazeef M, Sheehan JP.  New developments and updates in the management of moderate to severe hemophilia B. Journal of Blood Medicine 2016:7 27-38.
  • Bone Marrow Biopsy Quality: A Quality Improvement Project to Identify Factors Affecting Bone Marrow Biopsy Length and Find Strategies to Improve Overall Biopsy Quality. Poster presented at ASH 2015.
  • Nazeef M, Kahl BS. Mantle Cell Lymphoma:  First--‐line Therapy in Patients Not Eligible for Stem Cell Transplantation. Curr Treat Options Oncol. 2015 Jun;16(6):343


  • Gahvari ZJ, Callander NS. Intravascular large B-cell lymphoma in a Caucasian female with profound thrombocytopenia and dyspnea. Paper presented at: 59th Annual Wisconsin ACP Chapter Scientific Meeting; September 5, 2014; Wisconsin Dells, WI.
  • Braden AM, Wisinski KB, Eickhoff J, Schelman W, Bailey HH, Mulkerin D, Heideman J, Kolesar JM, Liu G.  A Phase I Study of ARQ 197 in Combination with Temsirolimus in Patients (Pts) with Advanced Solid Tumors.  Poster presented at American Society of Clinical Oncology Annual Meeting, Chicago, IL.  June 1, 2014
  • Braden AM, Stankowski RV, Engel JM, Onitilo AA.  Breast Cancer Biomarkers:  Risk Assessment, Diagnosis, Prognosis, Prediction of Treatment Efficacy and Toxicity, and Recurrence.  Review.  Current Pharmaceutical Design, 2014. DOI: 10.2174/1381612819666131125145517
  • Fletcher CD, Kahl BS. Central nervous system involvement in diffuse large B-cell lymphoma: an analysis of risks and prevention strategies in the post-rituximab era. Leuk Lymphoma. 2014 Feb 24. [Epub ahead of print] 
  • King JD, Casavant BP, Lang JM: Rapid Translation of Circulating Tumor Cell Biomarkers into Clinical Practice: Technology Development, Clinical Needs and Regulatory Requirements. Lab Chip, 14:24-31, 2014
  • Utilization and Evaluation of Non-Core Chemotherapy Regimens within an Academic Medical Center.
  • Jason R. Jared, PharmD; Mary Mably, RPh, BCOP; Rory Makielski, MD, Michael Fallon, PharmD, BCOP; Michael Reed, RPh, BCOP, BCPS; Jill Kolesar, PharmD, BCPS, FCCP; Glenn Liu, MD; Daniel Mulkerin, MD.
  • Poster presented at United HealthSystem Consortium annual pharmacy meeting on 12/6/2014 Anaheim, CA.  
  • Noelle K. LoConte, Tabraiz A. Mohammed, Emily R. Winslow, Heather B. Neuman, Maureen Smith, Glenn O. Allen, Jessica R. Schumacher. (2014). Effect of Neoadjuvant therapy in Patients with Resected Pancreatic Adenocarcinoma. Presented at GI ASCO. San Francisco, CA, Jan 16-18, 2014 
  • Lubner SJ, Mullvain JA, Hall LT, Pishvaian M, Mortimer JE, Oliver K, Heideman J, Weichert J, Liu G.  
  • American Society of Clinical Oncology National Meeting, Poster Session Carbone Cancer Center, University of Wisconsin  A phase I study of phospholipid ether [131I]-CLR1404 in patients with advanced solid tumors.
  • A Phase I Study of MK--‐2206 in Combination with Lapatinib in Patients with Advanced Solid Tumors Poster presentation in San Antonio Breast Cancer Symposium 2014. 
  • Rajguru S and Kahl BS. Mantle Cell Lymphoma-Management in Evolution. Chinese Clinical Oncology, 2014.
  • Saurabh Rajguru and Brad S. Kahl. Emerging Therapy for the Treatment of Mantle Cell Lymphoma. Journal of the National Comprehensive Cancer Network, 2014;12(9):1311-1318
  • Adam M. Petrich,  Mitul Gandhi, Borko Jovanvoic,  Jorge Castillo,  Saurabh Rajguru, et al. Impact of Induction Regimen and Stem Cell Transplantation on Outcomes in Patients with Double Hit Lymphoma: A Large Multicenter Retrospective Analysis. Blood, 2014;124(15):2354-2361
  • Saurabh Rajguru, Thorhildur Kristinsdottir, Jens Eickhoff, Chris Peterson, Anne M. Traynor, Brad S. Kahl. Y90 Ibritumomab Tiuxetan Plus Rituximab Maintenance As Initial Therapy For Patients With High Tumor Burden Follicular Lymphoma: A Wisconsin Oncology Network Study. Clinical Advances in Hematology & Oncology,2014; 12(8): 509-515.
  • Rampurwala M, Rocque GB, Burkard ME. (2014) Update on adjuvant chemotherapy for early breast cancer. Breast Cancer: Basic and Clinical Research. 8: 125-133


  • King JD, Reteseck J, Eickhoff, Traynor A, Hoang T, Campbell T: Integrated Onco-Palliative Care versus Standard Care for Patients with Metastatic Lung Cancer, a Single Institution Retrospective Review. ASCO Abstract Poster 2013
  • Smoothened inhibition leads to decreased proliferation and induces apoptosis in esophageal adenocarcinoma cells.  Zaidi AH, Komatsu Y, Kelly LA, Malhotra U, Rotoloni C, Kosovec JE, Zahoor H,  Makielski R, Bhatt A, Hoppo T, Jobe BA. Cancer Investigation. 2013 Aug;31(7):480-9.
  • Schelman WR, Mohammed TA, Traynor AM, Kolesar JM, Marnocha RM, Eickhoff J, Keppen M, Alberti DB, Wilding G, Takebe N, Liu G. A Phase I study of AT-101 with Cisplatin and Etoposide in patients with advanced solid tumors with an Expanded Cohort in Extensive-Stage Small Cell Lung Cancer. Investigational New Drugs. Investigational New Drugs. 2013 July 17. E-pub
  • Rajguru S, Carmichael L, Cetnar J. Determining the Value of High-Cost Therapies and Determining Cost of Cancer Care: The Patient Perspective. Poster Discussion Session, 2013 ASCO Annual Meeting, Chicago, IL
  • Rustagi T, Rampurwala M, Rai M, Fuentes S, Golioto M. (2013) Primary gastric combined adeno-small cell neuroendocrine carcinoma. Trop Gastroenterol. 34(3):197-9
  • Dasanu C, Bauer F, Codreanu I, Padmanabhan P, Rampurwala M. (2013) Plasmablastic hemato-lymphoid neoplasm with a complex genetic signature of Burkitt lymphoma responding to bortezomib. Hematology Oncology. 31; 164-166